SANUWAVE Health (SNWV) Net Cash Flow Growth (3y) (2013 - 2026)
SANUWAVE Health (SNWV) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn | -48.90% |
| 10 | SANUWAVE Health | 52.23 Mn | 41.45 Mn | 7.43 Mn | -4.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.20% |
| Dec 31, 2025 | 299.38% |
| Sep 30, 2025 | 73.73% |
| Jun 30, 2025 | -26.08% |
| Mar 31, 2025 | -79.14% |
| Dec 31, 2024 | 207.50% |
| Sep 30, 2024 | 97.32% |
| Jun 30, 2024 | -68.99% |
| Mar 31, 2024 | 34.64% |
| Dec 31, 2023 | 31.09% |
| Sep 30, 2023 | -26.39% |
| Jun 30, 2023 | 47.26% |
| Mar 31, 2023 | -35.53% |
| Dec 31, 2022 | -70.00% |
| Sep 30, 2022 | -51.20% |
| Jun 30, 2022 | 177.41% |
| Mar 31, 2022 | -4.69% |
| Dec 31, 2021 | -6.55% |
| Sep 30, 2021 | 29.58% |
| Jun 30, 2021 | -31.21% |